Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease and have a worse prognosis after percutaneous coronary interventions (PCI). The BioFreedom polymer-free biolimus-A9-eluting stent (PF-BES) has shown promising results in patients at high bleeding risk; however, its performance in CKD patients has yet to be analyzed.

Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry

Chiarito, Mauro;Stefanini, Giulio G;
2022-01-01

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease and have a worse prognosis after percutaneous coronary interventions (PCI). The BioFreedom polymer-free biolimus-A9-eluting stent (PF-BES) has shown promising results in patients at high bleeding risk; however, its performance in CKD patients has yet to be analyzed.
Aged
Cardiovascular Diseases
Female
Humans
Male
Middle Aged
Myocardial Infarction
Prospective Studies
Registries
Renal Insufficiency, Chronic
Sirolimus
Thrombosis
Drug-Eluting Stents
Percutaneous Coronary Intervention
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/69673
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact